Agilent Technologies (FRA:AG8) Beneish M-Score: -2.41 (As of Jun. 27, 2026)


FRA:AG8 Agilent Technologies Inc FRA:AG8
92 GF Score
Price €119.35
GF Value €127.48
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Agilent Technologies Beneish M-Score?

Agilent Technologies FRA:AG8 -0.25% 92 Beneish M-Score is -2.41 as of Jun. 27, 2026. GuruFocus rates FRA:AG8 with a GF Score™ of 92/100 and a GF Value™ of €127.48 (Fairly Valued). The stock has 1 warning sign investors should review. Among 195 Medical Diagnostics & Research companies, Agilent Technologies ranks worse than 69.23% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.41 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Agilent Technologies's Beneish M-Score or its related term are showing as below:

FRA:AG8' s Beneish M-Score Range Over the Past 10 Years
Min: -2.87   Med: -2.52   Max: -2.25
Current: -2.41

During the past 13 years, the highest Beneish M-Score of Agilent Technologies was -2.25. The lowest was -2.87. And the median was -2.52.


Agilent Technologies Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Agilent Technologies's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agilent Technologies Beneish M-Score Chart

Agilent Technologies Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.53 -2.33 -2.74 -2.66 -2.47

Agilent Technologies Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.61 -2.45 -2.47 -2.38 -2.41

FRA:AG8 vs WAT, IDXX, NTRA: Beneish M-Score Comparison

For the Diagnostics & Research subindustry, Agilent Technologies's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agilent Technologies Beneish M-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Agilent Technologies's Beneish M-Score falls into.


FRA:AG8
92GF Score
Agilent Technologies Inc FRA:AG8
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Agilent Technologies Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Agilent Technologies for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0429+0.528 * 1.0119+0.404 * 0.956+0.892 * 1.0102+0.115 * 1.1208
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9892+4.679 * -0.008246-0.327 * 0.9235
=-2.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Apr26) TTM:Last Year (Apr25) TTM:
Total Receivables was €1,281 Mil.
Revenue was 1568.925 + 1530.098 + 1598.599 + 1489.466 = €6,187 Mil.
Gross Profit was 846.45 + 805.046 + 850.41 + 761.016 = €3,263 Mil.
Total Current Assets was €4,072 Mil.
Total Assets was €11,171 Mil.
Property, Plant and Equipment(Net PPE) was €1,795 Mil.
Depreciation, Depletion and Amortization(DDA) was €237 Mil.
Selling, General, & Admin. Expense(SGA) was €1,528 Mil.
Total Current Liabilities was €1,940 Mil.
Long-Term Debt & Capital Lease Obligation was €2,609 Mil.
Net Income was 289.845 + 259.555 + 372.806 + 287.952 = €1,210 Mil.
Non Operating Income was 17.955 + 17.871 + 7.731 + 15.426 = €59 Mil.
Cash Flow from Operations was 236.835 + 228.068 + 468.155 + 310.234 = €1,243 Mil.
Total Receivables was €1,216 Mil.
Revenue was 1484.52 + 1623.846 + 1561.518 + 1454.916 = €6,125 Mil.
Gross Profit was 770.74 + 868.434 + 840.888 + 788.31 = €3,268 Mil.
Total Current Assets was €3,745 Mil.
Total Assets was €10,821 Mil.
Property, Plant and Equipment(Net PPE) was €1,702 Mil.
Depreciation, Depletion and Amortization(DDA) was €256 Mil.
Selling, General, & Admin. Expense(SGA) was €1,529 Mil.
Total Current Liabilities was €1,791 Mil.
Long-Term Debt & Capital Lease Obligation was €2,981 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1280.79 / 6187.088) / (1215.74 / 6124.8)
=0.20701 / 0.198495
=1.0429

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3268.372 / 6124.8) / (3262.922 / 6187.088)
=0.533629 / 0.527376
=1.0119

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (4072.365 + 1794.645) / 11170.575) / (1 - (3745.12 + 1701.68) / 10820.62)
=0.47478 / 0.496628
=0.956

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=6187.088 / 6124.8
=1.0102

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(255.95 / (255.95 + 1701.68)) / (236.995 / (236.995 + 1794.645))
=0.130745 / 0.116652
=1.1208

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1527.672 / 6187.088) / (1528.756 / 6124.8)
=0.246913 / 0.249601
=0.9892

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((2608.605 + 1939.995) / 11170.575) / ((2980.61 + 1790.68) / 10820.62)
=0.407195 / 0.440944
=0.9235

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1210.158 - 58.983 - 1243.292) / 11170.575
=-0.008246

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Agilent Technologies has a M-score of -2.44 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.41 mean?
Agilent Technologies (FRA:AG8) has a Beneish M-Score of -2.41 as of Jun. 27, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Agilent Technologies and its competitors. According to the industry distribution chart, Agilent Technologies ranks #135 out of 195 companies in the Medical Diagnostics & Research industry, placing it in the top 69.2%.
Is Agilent Technologies' Beneish M-Score too high?
Agilent Technologies' current Beneish M-Score is -2.41. Based on the distribution chart, Agilent Technologies ranks #135 out of 195 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Agilent Technologies has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' Beneish M-Score compare to WAT and IDXX?
According to the Medical Diagnostics & Research industry distribution chart, Agilent Technologies ranks #135 out of 195 companies for Beneish M-Score. This places Agilent Technologies in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Diagnostics & Research company?
A good Beneish M-Score depends on the Medical Diagnostics & Research industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Agilent Technologies and its competitors. Agilent Technologies's current Beneish M-Score is -2.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (FRA:AG8) is currently considered Fairly Valued. The stock's GF Value™ is €127.48, compared to a current price of €119.35 — trading 6.4% below its estimated fair value. The current Beneish M-Score is -2.41. Agilent Technologies' overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Agilent Technologies (FRA:AG8), the current Beneish M-Score is -2.41 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Agilent Technologies (FRA:AG8) Overvalued in 2026?

Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued. The current stock price of €119.35 is trading 6.4% below its estimated GF Value™ of €127.48. GuruFocus considers Agilent Technologies to be Fairly Valued.

Key valuation signals for FRA:AG8:

  • Beneish M-Score: -2.41
  • GF Value™: €127.48 vs. price of €119.35 (6.4% below fair value)
  • GF Score™: 92/100 with 1 warning sign

No single metric tells the full story. See the FRA:AG8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Agilent Technologies Business Description

Address 5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
92GF Score

Get the complete analysis for FRA:AG8

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€119.35
Price
€127.48
GF Value